Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials.
Saved in:
| Title: | Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. |
|---|---|
| Authors: | Chaudhuri R; Asthma/COPD Clinical Research Centre, Gartnavel General Hospital, Glasgow, UK; Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: rekha.chaudhuri@ggc.scot.nhs.uk., Rubin A; Department of Pulmonary Medicine, Santa Casa of Porto Alegre Hospital, Federal University of Health Ciencies of Porto Alegre (UFCSPA), Porto Alegre, Brazil., Sumino K; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USA., Lapa E Silva JR; Department of Medicine, Division of Infectious Diseases, Hospital Universiario Clememtino Fraga Filho, Rio de Janeiro, Brazil., Niven R; Manchester Academic Health Science Centre, The University of Manchester and Manchester Foundation Trust, Manchester, UK., Siddiqui S; University of Leicester, College of Life Sciences, Department of Respiratory Sciences, NIHR Biomedical Research Centre (Respiratory Theme), Leicester, UK., Klooster K; Faculty of Medical Sciences, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., McEvoy C; HealthPartners Specialty Center-Lung and Sleep Health, St Paul, MN, USA., Shah PL; Department of Respiratory Medicine, Chelsea and Westminster Hospital, London, UK; National Heart & Lung Institute, Imperial College, London, UK., Simoff M; Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI, USA., Khatri S; Asthma Center, Cleveland Clinic Foundation, Cleveland, OH, USA., Barbers R; Department of Clinical Medicine, Division of Pulmonary and Critical Care Medicine, Keck School of Medicine of USC, University of Southern California Hospital, Los Angeles, CA, USA., Mark Grubb G; Boston Scientific Corporation, Marlborough, MA, USA., McMullen EA; Boston Scientific Corporation, Marlborough, MA, USA., Olson JL; Boston Scientific Corporation, Marlborough, MA, USA., Laviolette M; Institut Universitaire de cardiologie et de pneumologie, Université Laval, Québec, QC, Canada. |
| Corporate Authors: | BT10+ Study Group |
| Source: | The Lancet. Respiratory medicine [Lancet Respir Med] 2021 May; Vol. 9 (5), pp. 457-466. Date of Electronic Publication: 2021 Jan 29. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
